Prospective study of endogenous tissue plasminogen activator and risk of stroke
- 16 April 1994
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 343 (8903), 940-943
- https://doi.org/10.1016/s0140-6736(94)90064-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- An epidemiologic assessment of thrombotic risk factors for cardiovascular diseaseCurrent Opinion in Lipidology, 1992
- Primary prevention of strokeThe Lancet, 1992
- Hematologic disorders and ischemic stroke. A selective review.Stroke, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).Circulation, 1989
- Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeThe American Journal of Cardiology, 1988
- Fibrinogen and Risk of Cardiovascular DiseaseJama-Journal Of The American Medical Association, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionThe New England Journal of Medicine, 1984